Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $264000.0.

  • Jaguar Health's Change in Receivables rose 62800.0% to $264000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $188000.0, marking a year-over-year increase of 12736.54%. This contributed to the annual value of -$440000.0 for FY2024, which is 1398.96% down from last year.
  • Jaguar Health's Change in Receivables amounted to $264000.0 in Q3 2025, which was up 62800.0% from -$50000.0 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Change in Receivables registered a high of $1.4 million during Q1 2021, and its lowest value of -$2.0 million during Q3 2021.
  • In the last 5 years, Jaguar Health's Change in Receivables had a median value of -$50000.0 in 2024 and averaged -$183578.9.
  • In the last 5 years, Jaguar Health's Change in Receivables crashed by 86239.32% in 2023 and then surged by 79677.42% in 2024.
  • Over the past 5 years, Jaguar Health's Change in Receivables (Quarter) stood at -$402000.0 in 2021, then skyrocketed by 78.86% to -$85000.0 in 2022, then soared by 136.47% to $31000.0 in 2023, then skyrocketed by 796.77% to $278000.0 in 2024, then dropped by 5.04% to $264000.0 in 2025.
  • Its Change in Receivables stands at $264000.0 for Q3 2025, versus -$50000.0 for Q2 2025 and -$304000.0 for Q1 2025.